Biotelemetry vs Indivior PLC
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Indivior PLC is the larger company by market value: $4.9 B against $34 M for Biotelemetry, 142 times as much (market caps of Oct 30, 2026 for Biotelemetry and Aug 1, 2026 for Indivior PLC). Indivior PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Indivior PLC made a net profit of $210 M, while Biotelemetry made a net loss of $21 M.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Biotelemetry BEAT · #22,561 in the world | Indivior PLC INDV · #3,650 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇬🇧 UK |
| Sector | Healthcare | Healthcare |
| Industry | — | Pharmaceutical |
| Founded | — | 1994 |
| Size | ||
| Market cap | $34 M | $4.9 B |
| Revenue | — | $1.2 B |
| Net income | $-21 M | $210 M▲ best |
| Employees | 1,500 | — |
| Valuation | ||
| P/E ratio | — | 10.8× |
| Price to sales | — | 3.5× |
| Price to book | 13.2× | — |
| Free cash flow yield | -42.7% | -1.9%▲ best |
| Profitability | ||
| Gross margin | — | 80.2% |
| Operating margin | — | 21.1% |
| Net margin | — | 16.9% |
| Return on equity | -989.2% | — |
| Growth | ||
| Revenue growth | — | 4.3% |
| Revenue growth, 3 years a year | — | 11.2% |
| Financial strength | ||
| Net debt to EBITDA | — | 0.3× |
| Interest cover | — | 6.9× |
| Cash | ||
| Free cash flow margin | — | -7.5% |
| Shareholder returns | ||
| Shareholder yield | — | 0.2% |
| Strength scores | ||
| Piotroski F-score | — | 4 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Biotelemetry or Indivior PLC?
Indivior PLC is the larger company by market value: $4.9 B against $34 M for Biotelemetry, 142 times as much (market caps of Oct 30, 2026 for Biotelemetry and Aug 1, 2026 for Indivior PLC). Indivior PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Biotelemetry or Indivior PLC?
Indivior PLC made a net profit of $210 M, while Biotelemetry made a net loss of $21 M.
More about Biotelemetry
More about Indivior PLC
Sources#
Every figure on this page comes from these, with the date shown next to it.